妇科恶性肿瘤多学科诊疗中国专家共识 （2022年版）.
- Published in:
- China Oncology, 2022, v. 32, n. 8, p. 747, doi. 10.19401/j.cnki.1007-3639.2022.08.010
- By:
- Publication type:
- Article
Works matching IS 10073639 AND DT 2022 AND VI 32 AND IP 8
Results: 10
1
2
ALK激酶域耐药突变的研究进展及未来应对策略.
- Published in:
- China Oncology, 2022, v. 32, n. 8, p. 736, doi. 10.19401/j.cnki.1007-3639.2022.08.009
- By:
- Publication type:
- Article
3
血浆长链非编码RNA H19对乳腺癌新辅助治 疗效果的预测价值.
- Published in:
- China Oncology, 2022, v. 32, n. 8, p. 727, doi. 10.19401/j.cnki.1007-3639.2022.08.008
- By:
- Publication type:
- Article
4
体重指数与年龄交互作用对乳腺癌患者预后影 响的研究.
- Published in:
- China Oncology, 2022, v. 32, n. 8, p. 719, doi. 10.19401/j.cnki.1007-3639.2022.08.007
- By:
- Publication type:
- Article
5
三阴性乳腺癌精准治疗研究的新进展与未来展望.
- Published in:
- China Oncology, 2022, v. 32, n. 8, p. 669, doi. 10.19401/j.cnki.1007-3639.2022.08.001
- By:
- Publication type:
- Article
6
卵巢功能抑制治疗雌激素受体阳性早期乳腺癌 的短期效应和长期生存的影响因素分析.
- Published in:
- China Oncology, 2022, v. 32, n. 8, p. 705, doi. 10.19401/j.cnki.1007-3639.2022.08.005
- By:
- Publication type:
- Article
7
微波消融在乳腺癌局部精准治疗中的新进展： 联合免疫治疗未来可期.
- Published in:
- China Oncology, 2022, v. 32, n. 8, p. 698, doi. 10.19401/j.cnki.1007-3639.2022.08.004
- By:
- Publication type:
- Article
8
液体活检在乳腺癌精准治疗中的应用进展及展望.
- Published in:
- China Oncology, 2022, v. 32, n. 8, p. 688, doi. 10.19401/j.cnki.1007-3639.2022.08.003
- By:
- Publication type:
- Article
9
前哨淋巴结时代乳腺癌的精准区域处理：演进 与展望.
- Published in:
- China Oncology, 2022, v. 32, n. 8, p. 680, doi. 10.19401/j.cnki.1007-3639.2022.08.002
- By:
- Publication type:
- Article
10
sST2在免疫检查点抑制剂相关不良反应风险 预测中的价值.
- Published in:
- China Oncology, 2022, v. 32, n. 8, p. 712, doi. 10.19401/j.cnki.1007-3639.2022.08.006
- By:
- Publication type:
- Article